Cardiology Today -- One-year results from the CARDia trial did not indicate that percutaneous coronary intervention with stenting was noninferior to CABG in patients with diabetes and symptomatic multivessel coronary artery disease.
Cardiology Today -- One-year results from the CARDia trial did not indicate that percutaneous coronary intervention with stenting was noninferior to CABG in patients with diabetes and symptomatic multivessel coronary artery disease.